Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755546 · ClinicalTrials.gov registry record · Phase 3
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3 study, sponsored by BioDelivery Sciences International.
- Completed
- Registry status
- Phase 3
- Development phase
- 304
- Enrollment target
NCT01755546 is a Phase 3 study that has completed, run by BioDelivery Sciences International. The registered enrollment target is 304 participants.
The verdict
NCT01755546, a Phase 3 study, has completed, sponsored by BioDelivery Sciences International.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 304 participants
- Enrollment target
Study Summary
The purpose of the long-terms study is to evaluate the safety, tolerability, and analgesic efficacy of EN3409 in subjects with moderate to severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
Interventions
- DRUG EN3409
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755546
The ClinicalTrials.gov registry entry for NCT01755546 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioDelivery Sciences International, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EN3409 is the first listed.
NCT01755546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755546 about?
NCT01755546 is a clinical study titled "Long-term Open-Label Safety Study to Evaluate EN3409". The purpose of the long-terms study is to evaluate the safety, tolerability, and analgesic efficacy of EN3409 in subjects with moderate to severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
What is the current status of trial NCT01755546?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 304 participants. The study started on 2012-12. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01755546?
The interventions under investigation include: EN3409 (DRUG).
Who is sponsoring clinical trial NCT01755546?
This trial is sponsored by BioDelivery Sciences International, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.